Form 4 Tracker
Enliven Therapeutics, Inc.
ELVN

37 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 20, 2025Jun 20 8:02 PMLyssikatos Joseph P
Proposed Sale
12,500$21.57$269.6K—

View →

Jun 17, 2025Jun 17 8:15 PMKintz Samuel
Proposed Sale
12,500$23.09$288.6K—

View →

Jun 13, 2025Jun 13 8:08 PMHohl Benjamin
Proposed Sale
3,000$19.99$60.0K—

View →

Jun 9, 2025Jun 9 8:21 PMPatel Anish
Proposed Sale
6,667$20.74$138.3K—

View →

Jun 3, 2025Jun 3 9:34 PMKintz Samuel
Proposed Sale
7,500$19.14$143.6K—

View →

Jun 3, 2025Jun 3 9:14 PMLyssikatos Joseph P
Proposed Sale
7,500$19.14$143.6K—

View →

May 27, 2025May 27 8:03 PMHohl Benjamin
Proposed Sale
3,250$16.40$53.3K—

View →

May 19, 2025May 19 8:22 PMKintz Samuel
Proposed Sale
5,000$16.86$84.3K—

View →

May 19, 2025May 19 8:21 PMLyssikatos Joseph P
Proposed Sale
5,000$16.86$84.3K—

View →

May 7, 2025May 7 8:11 PMPatel Anish
Proposed Sale
6,667$19.69$131.3K—

View →

May 1, 2025May 1 8:03 PMLyssikatos Joseph P
Proposed Sale
7,500$18.94$142.1K—

View →

May 1, 2025May 1 8:02 PMKintz Samuel
Proposed Sale
7,500$18.94$142.1K—

View →

Apr 21, 2025Apr 21 8:28 PMLyssikatos Joseph P
Proposed Sale
5,000$16.53$82.7K—

View →

Apr 17, 2025Apr 17 8:19 PMKintz Samuel
Proposed Sale
5,000$16.07$80.3K—

View →

Apr 14, 2025Apr 14 8:54 PMPatel Anish
Proposed Sale
2,010$16.51$33.2K—

View →

Apr 14, 2025Apr 14 8:48 PMPatel Anish
Proposed Sale
2,010$16.51$33.2K—

View →

Apr 7, 2025Apr 7 8:09 PMPatel Anish
Proposed Sale
6,667$18.69$124.6K—

View →

Mar 27, 2025Mar 27 8:01 PMHohl Benjamin
Proposed Sale
4,250$20.58$87.5K—

View →

Mar 19, 2025Mar 19 8:18 PMLyssikatos Joseph P
Proposed Sale
12,500$20.28$253.5K—

View →

Mar 18, 2025Mar 18 9:33 PMKintz Samuel
Proposed Sale
21,531$21.04$453.0K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 14, 2026Oct 16 8:42 PMKristine M BallDirector
Grant/Award
23,394$39.2823,394(D)

View →

Oct 1, 2026Oct 5 8:57 PMScott J. GarlandDirector
Option Exercise
13,000$15.4746,372(D)

View →

Sep 17, 2026Sep 21 9:23 PMBenjamin HohlCHIEF FINANCIAL OFFICER
Option Exercise
3,982$14.85181,018(D)

View →

Sep 17, 2026Sep 21 9:22 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48106,268(D)

View →

Aug 17, 2026Aug 19 8:16 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48111,268(D)

View →

Aug 4, 2026Aug 7 12:18 AMMika K DerynckDirector
Option Exercise
158,795$25.280(D)

View →

Jul 17, 2026Jul 21 9:24 PMBenjamin HohlCHIEF FINANCIAL OFFICER
Option Exercise
1,072$2.4884,966(D)

View →

Jul 17, 2026Jul 21 9:23 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48116,268(D)

View →

Jun 17, 2026Jun 22 9:13 PMBenjamin HohlCHIEF FINANCIAL OFFICER
Option Exercise
6,018$2.4886,038(D)

View →

Jun 17, 2026Jun 22 9:11 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48121,268(D)

View →

May 18, 2026May 20 8:18 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48126,268(D)

View →

Apr 17, 2026Apr 22 12:40 AMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48131,268(D)

View →

Mar 25, 2026Mar 27 8:57 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
40,000$2.48136,268(D)

View →

Mar 17, 2026Mar 19 9:50 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
5,000$2.48176,268(D)

View →

Mar 10, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
10,129$2.48181,268(D)

View →

Mar 9, 2026Mar 11 9:32 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
29,871$2.48191,397(D)

View →

Feb 17, 2026Feb 19 11:36 PMHelen Louise CollinsCHIEF MEDICAL OFFICER
Option Exercise
45,000$2.48221,268(D)

View →

Feb 12, 2026Feb 18 1:01 AMLori Anne KunkelDirector
Grant/Award
17,126$27.1617,126(D)

View →

Feb 12, 2026Feb 18 1:00 AMRichard A. HeymanDirector
Grant/Award
19,234$27.1619,234(D)

View →

Feb 12, 2026Feb 18 12:59 AMRishi GuptaDirector
Grant/Award
35,569$27.161,580(D)

View →

Page 1 of 2

Next →